Lexmark’s NilRead enterprise viewer receives FDA 510(k) Class II clearance

Evan Godt | | Health Imaging | Enterprise Imaging

Lexmark has announced that it received 510(k) Class II clearance from the FDA for the NilRead enterprise viewer. Providers in the U.S. are now able to use the web-based, zero-footprint viewer to review and interpret a variety of imaging studies, including mammography and digital breast tomosynthesis.

The 510(k) Class II clearance is the first for a zero-footprint viewer that supports mammography and tomosynthesis, according to Claudio Gatti, chief technology officer, visualization, for Lexmark Enterprise Software.

NilRead comes in multiple configurations for different workflows, including core, clinical and interpretation. The FDA clearance includes the entire NilRead product family

Lexmark picked up the NilRead line of medical image viewing products in January when it acquired Toronto-based Claron Technology.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Related Content

Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
Residents' structured reports get boost from software assistance
Do large language models help or hinder workflows related to radiology reports?
Telehealth visits not to blame for uptick in imaging orders, study shows
Up to half of medical organizations either already using or preparing to implement AI

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.